Analyst firms · Morgan Stanley · EVFM
Morgan Stanley EVFM price target and rating history
Evofem Biosciences Inc. (EVFM) · Health Care
Morgan Stanley rates Evofem Biosciences Inc. (EVFM) Underweight with a $0.53 price target, as of its latest action on Mar 4, 2022. It has published 3 rating actions on EVFM since August 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Underweight
- Price target
- $0.53
- Median target, all firms
- Too few
- Actions on EVFM
- 3
Morgan Stanley price target on EVFM
Every Morgan Stanley rating on EVFM
- Mar 4, 2022
- Oct 14, 2021
- Aug 12, 2021
Questions about Morgan Stanley and EVFM
- What is Morgan Stanley's price target for EVFM?
- Morgan Stanley's latest stated price target for Evofem Biosciences Inc. (EVFM) is $0.53, from its action on Mar 4, 2022.
- What is Morgan Stanley's rating on EVFM?
- Morgan Stanley rates EVFM Underweight, a bearish rating, as of Mar 4, 2022.
- When did Morgan Stanley last change its view on EVFM?
- On Mar 4, 2022, Morgan Stanley raises its price target to $0.53 from $0.50, keeps Underweight.
All Morgan Stanley ratingsEVFM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.